相关实验视频
Updated: Sep 18, 2025

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.6K
拉莫特里金和抗发作药物在HLH:一个系统的审查
Yaswanta K Gummadi1, Ashley E Sutherland2, Kristin M Ikeda3
1Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
British journal of haematology
|June 23, 2025
概括
拉莫特里金和抗发作药物可以引起血细胞性淋巴细胞细胞症 (HLH) 和药物诱导过敏综合征 (DIHS). 一项系统性审查发现了这些严重疾病之间的显著临床重叠.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 抗发作药物,包括拉莫特里金,与严重的全身反应有关.
- 血细胞淋巴细胞化 (HLH) 和药物诱导过敏综合征 (DIHS) 是不同的,但重叠的疾病.
- 了解HLH和DIHS之间的关系对于准确的诊断和管理至关重要.
研究的目的:
- 系统地审查HLH和DIHS的临床,实验室和病理发现.
- 确定和描述HLH和DIHS之间的临床重叠.
- 为了澄清骨髓活检中血栓细胞瘤症的诊断意义.
主要方法:
- 系统的文献审查.
- 对临床表现,实验室结果和病理发现的分析.
- 诊断标准的比较和HLH和DIHS的重叠特征.
主要成果:
- 在HLH和DIHS之间存在显著的临床重叠.
- 确定了共同的临床,实验室和病理特征.
- 骨髓活检上的血细胞分裂是支持性的,但不是HLH的病原体.
结论:
- HLH和DIHS具有相当大的临床特征,使诊断复杂化.
- 区分HLH和DIHS需要仔细评估多个参数.
- 仅仅血细胞瘤的存在不足以确定HLH诊断.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
461
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
461
Antiepileptic Drugs: Glutamate Antagonists
527
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
527
Antiepileptic Drugs: Potassium Channel Activators
289
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
289
Antiepileptic Drugs: Sodium Channel Blockers
950
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
950
Epilepsy and Seizures: Overview
296
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
Antiepileptic Drugs: GABAergic Pathway Potentiators
681
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
681

